Subsequent Events	12 Months Ended
Dec. 31, 2024
Subsequent Events [Abstract]
SUBSEQUENT EVENTS	NOTE 13 – SUBSEQUENT EVENTS On January 9, 2025, the Company entered into a financing agreement with 1800 Diagonal Lending LLC (“1800 Diagonal”) to borrow $49,200. The note matures on October 30, 2025, bears interest at 12%, with a default rate of 22%, and is convertible, commencing 180 days after the date of issuance, into common shares of the Company. The conversion price is to be calculated at 61% of the average of the lowest trading price of the Company’s common stock for the previous ten trading days prior to the date of conversion. The lender agrees to limit the amount of stock received to less than 4.99% of the total outstanding common stock. There are no warrants or options attached to this note, and the Company has reserved 114,000,000 shares of common stock for conversion. Net proceeds from the loan were $40,000, after legal fees and borrowing costs of $9,200. On May 29, 2025, the Board of Directors authorized and approved the issuance of an aggregate 400,000,000 shares of the common stock to officers/directors/advisors/consultants to the Company for services rendered at a value of $0.0004 per share, based on the daily closing trading price of the Company’s common stock, including 200,000,000 shares to the Company’s Chief Executive Officer/Director and 25,000,000 to an independent Director. In October 2025, the Company commenced a $1 million fractional unit offering, in increments of $5,000, consisting of Common and Preferred Securities under a term sheet to certain accredited investors, who had advanced monies to the Company over a period of 5 months in the 2025 fiscal year. The Company has received an aggregate $384,208 consideration from four lenders consisting of $236,562 cash and conversion of $125,000 in outstanding notes and related accrued interest of $22,646, all of which is converted by the documents into the fractional units set forth above. The Fractional Units were offered at $5,000 per one twentieth of one Unit consist of 7,500,000 shares of common stock and 5,000 shares of Series B Preferred Stock which participates in 1/20^th of 1% of an assigned royalty of licensing fees for life of patents and licenses of BlackStar. (for each share of Series B Preferred Stock -0.0025%). The Company will issue 576,312,092 shares of common stock and 384,208 shares of Preferred Series B stock to the investors, none of which have been issued as of the date of these financial statements. The Company has analyzed its operations subsequent to December 31, 2024 through the date that these financial statements were issued, and has determined that it does not have any additional material subsequent events to disclose.

Subsequent Events

12 Months Ended

Dec. 31, 2024

NOTE 13 – SUBSEQUENT EVENTS

On January 9, 2025, the Company entered into a financing agreement with 1800 Diagonal Lending LLC (“1800 Diagonal”) to borrow $49,200. The note matures on October 30, 2025, bears interest at 12%, with a default rate of 22%, and is convertible, commencing 180 days after the date of issuance, into common shares of the Company. The conversion price is to be calculated at 61% of the average of the lowest trading price of the Company’s common stock for the previous ten trading days prior to the date of conversion. The lender agrees to limit the amount of stock received to less than 4.99% of the total outstanding common stock. There are no warrants or options attached to this note, and the Company has reserved 114,000,000 shares of common stock for conversion. Net proceeds from the loan were $40,000, after legal fees and borrowing costs of $9,200.

On May 29, 2025, the Board of Directors authorized and approved the issuance of an aggregate 400,000,000 shares of the common stock to officers/directors/advisors/consultants to the Company for services rendered at a value of $0.0004 per share, based on the daily closing trading price of the Company’s common stock, including 200,000,000 shares to the Company’s Chief Executive Officer/Director and 25,000,000 to an independent Director.

In October 2025, the Company commenced a $1 million fractional unit offering, in increments of $5,000, consisting of Common and Preferred Securities under a term sheet to certain accredited investors, who had advanced monies to the Company over a period of 5 months in the 2025 fiscal year. The Company has received an aggregate $384,208 consideration from four lenders consisting of $236,562 cash and conversion of $125,000 in outstanding notes and related accrued interest of $22,646, all of which is converted by the documents into the fractional units set forth above. The Fractional Units were offered at $5,000 per one twentieth of one Unit consist of 7,500,000 shares of common stock and 5,000 shares of Series B Preferred Stock which participates in 1/20^th of 1% of an assigned royalty of licensing fees for life of patents and licenses of BlackStar. (for each share of Series B Preferred Stock -0.0025%). The Company will issue 576,312,092 shares of common stock and 384,208 shares of Preferred Series B stock to the investors, none of which have been issued as of the date of these financial statements.

The Company has analyzed its operations subsequent to December 31, 2024 through the date that these financial statements were issued, and has determined that it does not have any additional material subsequent events to disclose.